A carregar...
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Diabetes management during Ramadan fasting is challenging to the physician in terms of minimizing the risk of hypoglycemia. As compared to oral hypoglycemic agents (OHAs) and sulfonylureas (SUs), which carry a higher and significant risk of hypoglycemia, newer antidiabetic agents such as dipeptidyl...
Na minha lista:
| Publicado no: | Diabetes Metab Syndr Obes |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404947/ https://ncbi.nlm.nih.gov/pubmed/25931826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S54683 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|